| Article | Date | Source |
|---|
| Bristol-Myers Squibb Company Trading Near $30.34 Resistance Level? | -- | Pharmaceutical - Moreover |
| Trends and Analysis on Bristol-Myers Squibb Co.: PharmaVitae Profile | -- | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company (BMY) Announces the Winners of the 20 | -- | Biotechnology - Moreover |
| Bristol-Myers Squibb Announces the Winners of the 2011 REYATAZ® (atazanavir sulfate) âFight HIV Your Wayâ Contest | -- | Biotechnology - Moreover |
| Bristol-Myers Squibb Company (BMY) to Announce Results for Second Quarter 20 | -- | Biotechnology - Moreover |
| Bristol-Myers Squibb Announces U.S. FDA Approval of NULOJIX(R) (belatacept) | -- | Pharmaceutical - Moreover |
| Bristol-Myers Squibb reaps biologics in ZymoGenetics windfall | -- | Nature Biotechnology |
| Bristol-Myers Squibb Company Exec Writes Book for Punishment | May 17, 2012 | BioSpace |
| New Data from Bristol-Myers Squibb Oncology Portfolio to be Presented at 2012 American Society of Clinical Oncology (ASCO) Annual Meeting | May 16, 2012 | FDA News - Business Wire |
| Bristol-Myers Squibb Company' Plavix's New Generic Status Could be Boon for Patients | May 16, 2012 | BioSpace - Breaking News |
| Bristol-Myers Squibb Company and Tsinghua University Enter Strategic Partnership | May 15, 2012 | BioSpace - Breaking News |
| U.S. FDA Approves Bristol-Myers Squibb Devens Biologics Manufacturing Facility for Production of ORENCIA® (abatacept) | May 15, 2012 | FDA News - Business Wire |
| Bristol-Myers Squibb Foundation Announces $15 Million Expansion of Together on Diabetes® to China and India | May 15, 2012 | Pharma News - Business Wire |
| Bristol-Myers Squibb and Tsinghua University Enter Strategic Partnership | May 15, 2012 | Biotech News - Business Wire |
| Bristol-Myers Squibb to Present New Data on ORENCIA(R)▼ (abatacept) at the European League Against Rheumatism (EULAR) 2012 Congress | May 14, 2012 | Biotech News - PR Newswire |
| Bristol-Myers Squibb to Present New Data on ORENCIA® (abatacept) at the European League Against Rheumatism (EULAR) 2012 Congress | May 14, 2012 | Pharma News - Business Wire |
| Gilead Sciences, Inc.-Bristol-Myers Squibb Company's Experimental Hepatitis C Drug Cured 88% Post-Therapy | April 19, 2012 | BioSpace - Breaking News |
| Bristol-Myers Squibb Company, Johnson & Johnson,and Medivir AB Strike Another Deal to Conquer Hep C | April 18, 2012 | BioSpace - Breaking News |
| Bristol-Myers Squibb Company Expands Hepatitis C Accord With Johnson & Johnson,Medivir AB | April 18, 2012 | BioSpace - Breaking News |
| Amylin Reportedly Rejected Bristol-Myers Squibb's $3.5B Takeover Offer | March 29, 2012 | Inside Industry - Gen |
| Bristol-Myers Squibb Company Cited Again for Monkey Deaths | March 20, 2012 | BioSpace |
| Little Benefit From Pfizer Inc. & Bristol-Myers Squibb Company Bloodthinner | March 16, 2012 | BioSpace - Breaking News |
| Bristol-Myers Squibb Company CEO Gets 27% Pay Increase, GlaxoSmithKline CEO Pay Package Doubles | March 13, 2012 | BioSpace - Breaking News |
| Radiation Blast May Turbocharge Bristol-Myers Squibb Company Melanoma Drug, Memorial Sloan-Kettering Cancer Center Report Shows | March 08, 2012 | BioSpace |
| Radiation Blast May Turbocharge Bristol-Myers Squibb Company Melanoma Drug, Report Shows | March 08, 2012 | BioSpace - Breaking News |
| FDA Delays Decision on Bristol-Myers Squibb Company, Pfizer Inc. Anti-Clot Drug By 3 Months | March 01, 2012 | BioSpace |
| Bristol-Myers Squibb to Take Part in Citi 2012 Global Health Care Conference | February 21, 2012 | Pharma News - Business Wire |
| Bristol-Myers Squibb Foundation Announces Grants Focused on Prevention, Diagnosis and Care of Hepatitis B and Hepatitis C in Asia | February 18, 2012 | Pharma News - Business Wire |
| Drugmakers Including Achillion Pharmaceuticals, Inc. and Bristol-Myers Squibb Company Seek Deals to Gain Share of Future Hep C Combo Pill | February 15, 2012 | BioSpace |
| Bristol-Myers Squibb Company Completes Acquisition of Inhibetex Therapeutics Inc. | February 14, 2012 | BioSpace - Breaking News |
| Bristol-Myers Squibb Completes Acquisition of Inhibitex, Inc. | February 13, 2012 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company Announces Successful Completion of Cash Tender Offer for Shares of Inhibitex, Inc. | February 13, 2012 | BioSpace - Breaking News |
| Bristol-Myers Squibb Announces Successful Completion of Cash Tender Offer for Shares of Inhibitex, Inc. | February 13, 2012 | Pharma News - Business Wire |
| Sanofi (France), Bristol-Myers Squibb Company Receive Nearly $445 Million From Apotex Inc. Over Generic Plavix | February 09, 2012 | BioSpace |
| Bristol-Myers Squibb to Present at Leerink Swann 2012 Global Healthcare Conference | February 08, 2012 | Pharma News - Business Wire |
| Sanofi (France) and Bristol-Myers Squibb Company Collect Damages in Plavix Patent Litigation With Apotex Inc. | February 08, 2012 | BioSpace |
| Sanofi and Bristol-Myers Squibb Collect Damages in Plavix Patent Litigation with Apotex | February 08, 2012 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Inhibetex Therapeutics Inc. | February 03, 2012 | BioSpace - Breaking News |
| Bristol-Myers Squibb Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Inhibitex, Inc. | February 03, 2012 | Pharma News - Business Wire |
| Bristol-Myers Squibb reports higher Q4 net income, provides guidance for 2012 | January 30, 2012 | Biotechnology - Moreover |
| Bristol-Myers Squibb Company Delivers Solid Fourth Quarter Capping a Year Highlighted by New Product Approvals, Continued Execution of Strategic Transactions and Good Operating Performance | January 27, 2012 | BioSpace |
| Bristol-Myers Squibb Delivers Solid Fourth Quarter Capping a Year Highlighted by New Product Approvals, Continued Execution of Strategic Transactions and Good Operating Performance | January 26, 2012 | Pharma News - Business Wire |
| Bristol-Myers Squibb Names Gerald L. Storch to Board of Directors | January 24, 2012 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company Rebuked Over Death of Lab Monkey | January 20, 2012 | BioSpace |
| Bristol-Myers Squibb Company Hepatitis C Pills Clear Virus Without Injections | January 19, 2012 | BioSpace |
| FDA Rejects AstraZeneca PLC's and Bristol-Myers Squibb Company's Dapagliflozin for Type 2 Diabetes | January 19, 2012 | BioSpace |
| Bristol-Myers Squibb Announces Charitable Donation of $6.9 Million to Support Cancer Patients | January 19, 2012 | Pharma News - Business Wire |
| Bristol-Myers Squibb and AstraZeneca Receive Complete Response Letter from U.S. Food and Drug Administration for Dapagliflozin | January 19, 2012 | FDA News - Business Wire |
| Bristol-Myers Squibb Buys Inhibitex for $2.5 Billion | January 12, 2012 | Burrill Report |
| The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Inhibitex, Inc. in Connection with the Sale of the Company to Bristol-Myers Squibb Co. | January 11, 2012 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company to Acquire Inhibitex, Inc. for $2.5 Billion | January 09, 2012 | BioSpace |
| BT, Bristol-Myers Squibb extend contract | January 09, 2012 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb extends managed network service pact | January 09, 2012 | Pharmaceutical - Moreover |
| Pharma giant Bristol-Myers Squibb standardises network infrastructure | January 06, 2012 | Pharmaceutical - Moreover |
| Ensemble, Bristol-Myers Squibb extend collaboration | January 06, 2012 | Pharmaceutical - Moreover |
| Ensemble Therapeutics Corporation Extends Macrocycle Drug Discovery Alliance with Bristol-Myers Squibb Company (BMY) | January 05, 2012 | Biotechnology - Moreover |
| Bristol-Myers Squibb outsources network duties to British Telecom | January 05, 2012 | FierceBiotech IT |
| Bristol-Myers Squibb to Announce Results for Fourth Quarter, Full Year 2011 on January 26 | January 05, 2012 | Pharma News - Business Wire |
| Ensemble Therapeutics Corporation Extends Macrocycle Drug Discovery Alliance with Bristol-Myers Squibb Company | January 05, 2012 | BioSpace - Breaking News |
| Stock Market News Briefs: Bristol-Myers Squibb Company, Devon Energy, MGIC Investment, Rambus, China Petroleum & Chemical, Teva Pharmaceutical Industries Limited, USX Corporation | January 04, 2012 | Pharmaceutical - Moreover |
| Breakout Stocks: Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA), Bristol-Myers Squibb Co. (NYSE: BMY) | January 03, 2012 | Pharmaceutical - Moreover |
| Teva Pharmaceutical Industries Limited Taps Bristol-Myers Squibb Company Exec as New CEO; Appointment Hints at More Acquisitions to Come | January 03, 2012 | BioSpace |
| Bristol-Myers Squibb Company Release: BRISK-PS Study with Investigational Compound Brivanib in Hepatocellular Carcinoma Completed | December 28, 2011 | BioSpace - Breaking News |
| Study Challenges FDA on Bristol-Myers Squibb Company and Sanofi (France)'s Plavix | December 28, 2011 | BioSpace |
| Bristol-Myers Squibb to expand activity in Israel | December 28, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb and the Gladstone Institutes Enter Three-Year Discovery Partnership in Alzheimer’s Disease | December 22, 2011 | Pharma News - Business Wire |
| The Week in Review: Simcere Pharmaceutical Group and Bristol-Myers Squibb Company Add Cardiovascular Drug to Partnership | December 19, 2011 | Pharmaceutical - Moreover |
| Simcere expands collaboration with Bristol-Myers Squibb to develop cardiovascular compound | December 15, 2011 | Pharmaceutical - Moreover |
| Simcere Pharmaceutical Group and Bristol-Myers Squibb Company (BMY) Enter Innovative Partnership to Develop Cardiovascular Compound | December 15, 2011 | Pharmaceutical - Moreover |
| NeurOp Corporation Announces Extension to Drug Discovery Collaboration with Bristol-Myers Squibb Company | December 14, 2011 | BioSpace - Breaking News |
| Bristol-Myers Squibb announces second pact with Simcere | December 14, 2011 | Pharmaceutical - Moreover |
| SIMCERE PHARMACEUTICAL GROUP (ADR): Simcere and Bristol-Myers Squibb Enter Inno.. | December 14, 2011 | Pharmaceutical - Moreover |
| SIMCERE PHARMACEUTICAL GROUP (ADR) : Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Cardiovascular Compound | December 14, 2011 | Pharmaceutical - Moreover |
| Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Cardiovascular Compound | December 14, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company,AstraZeneca PLC Release: New Data Show Investigational Compound Dapagliflozin When Added to Glimepiride Maintained Reductions in Blood Sugar Levels in Adults with Type 2 Diabetes Over 48 Weeks of Treatment | December 08, 2011 | BioSpace - Breaking News |
| Bristol-Myers Squibb Company,AstraZeneca AB Release: New Data Show Investigational Compound Dapagliflozin When Added to Glimepiride Maintained Reductions in Blood Sugar Levels in Adults with Type 2 Diabetes Over 48 Weeks of Treatment | December 08, 2011 | BioSpace - Breaking News |
| Bristol-Myers Squibb enters clinical collaboration agreement with Tibotec Pharmaceuticals | December 06, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company, Johnson & Johnson Ink Hepatitis C Pact | December 05, 2011 | BioSpace - Breaking News |
| Bristol-Myers Squibb Enters Clinical Collaboration Agreement with Tibotec Pharmaceuticals for Phase II Combination Study i | December 03, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company Enters Clinical Collaboration Agreement with Tibotec Pharmaceuticals Ltd for Phase II Combination Study in Patients Chronically Infected with Hepatitis C | December 02, 2011 | BioSpace - Breaking News |
| Bristol-Myers Squibb (BMY) Enters Daclatasvir Collaboration with Tibotec Pharma | December 02, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Enters Clinical Collaboration Agreement with Tibotec Pharmaceuticals for Phase II Combination Study in Patients Chronically Infected with Hepatitis C | December 02, 2011 | Biotech News - Business Wire |
| Bristol-Myers Squibb Company, Pfizer Inc. Report FDA's Acceptance of Eliquis NDA for Priority Review | November 29, 2011 | BioSpace - Breaking News |
| Bristol-Myers Squibb Company and AstraZeneca PLC's ONGLYZA?? (saxagliptin) Approved for Use in Europe as Combination Therapy With Insulin (With or Without Metformin) in Adults With Type 2 Diabetes | November 28, 2011 | BioSpace - Breaking News |
| Equity Research on Pfizer Inc. and Bristol-Myers Squibb Co. - Major Drug Manufacturers Focus on R&D and Emerging Markets as Patent Expiries Hit | November 22, 2011 | Marketwire - Pharma and Biotech |
| Bristol-Myers Squibb Signs New Agreement to Expand Access to Reyataz(R) atazanavir sulfate in Brazil | November 21, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company and AstraZeneca AB Release: Meta-Analysis of Clinical Data on Cardiovascular Safety Presented for Investigational Compound Dapagliflozin in Adult Patients with Type 2 Diabetes | November 17, 2011 | BioSpace - Breaking News |
| Bristol-Myers Squibb Foundation funding Camden diabetes care | November 17, 2011 | Health News - BizJournals.com |
| Bristol-Myers Squibb Company Release: Meta-Analysis of Clinical Data on Cardiovascular Safety Presented for Investigational Compound Dapagliflozin in Adult Patients with Type 2 Diabetes
| November 17, 2011 | BioSpace - Breaking News |
| Bristol-Myers Squibb Foundation Awards $2.34 Million in Grants to Help Prisoners with Mental Illness Return to Community | November 17, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb: Performance, Capabilities, Goals and Strategies in the ... | November 16, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market | November 15, 2011 | Pharma News - PR Newswire |
| Bristol-Myers Squibb enters technology transfer agreement with Brazilian health ministry to expand access to Reyataz | November 15, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Foundation’s Together on Diabetes® Initiative Marks First Anniversary by Awarding $18.4 Million in Grants to Help Communities Hardest Hit by Diabetes, Issuing Annual Report | November 14, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company, Pfizer Inc. Clot Drug Fails to Help Ill Patients | November 14, 2011 | BioSpace |
| Brazilian Ministry of Health, Bristol-Myers Squibb sign technology transfer agreement for Reyataz | November 14, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company (BMY) Signs New Agreement to Expand Access to Reyataz® (atazanavir sulfate) in Brazil | November 11, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Signs New Agreement to Expand Access to Reyataz® (atazanavir sulfate) in Brazil | November 11, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company Signs New Agreement to Expand Access to Reyataz?? (atazanavir sulfate) in Brazil | November 11, 2011 | BioSpace |
| BRISTOL MYERS SQUIBB CO. : Bristol-Myers Squibb Signs New Agreement to Expand Access to Reyataz® (atazanavir sulfate) in Brazil | November 11, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Signs New Agreement to Expand Access to Reyataz (atazanavir sulfate) in Brazil | November 11, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb (BMY) Enters HIV Therapy Tech Transfer Agreement with Brazil | November 11, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Signs New Agreement to Expand Access to Reyataz® (atazanavir sulfate) in Brazil | November 11, 2011 | Pharma News - Business Wire |
| Dako A/S Enters New Collaboration With Bristol-Myers Squibb Company on Pharmacodiagnostics | November 09, 2011 | BioSpace - Breaking News |
| 12-Week On-Treatment Results from Large Phase IIb Study (COMMAND-1) of Bristol-Myers Squibb Company???s NS5A Inhibitor Daclatasvir Support Anti-HCV Activity and Safety Profile Observed in Earlier Studies
| November 08, 2011 | BioSpace - Breaking News |
| All-Oral Treatment Regimen of Bristol-Myers Squibb Company???s Investigational NS5A and NS3 Inhibitors Achieved 90% Sustained Virologic Response (SVR12) in Phase II Study Sentinel Cohort of Genotype 1b Null Responders | November 08, 2011 | BioSpace - Breaking News |
| FDA Approves Bristol-Myers Squibb Company's Erbitux to Treat Late-stage Head and Neck Cancer | November 08, 2011 | BioSpace |
| Bristol-Myers Squibb Company Release: New 12 Week, Interferon-Free Treatment Arms Added to All-Oral Combination Study of PSI-7977 and Daclatasvir (BMS-790052) for HCV Genotype 1 | November 04, 2011 | BioSpace - Breaking News |
| ASLAN Pharmaceuticals and Bristol-Myers Squibb Enter Innovative Partnership to License and Develop Investigational Oncology Compound | November 03, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb to Present at Credit Suisse Health Care Conference | November 02, 2011 | Pharma News - Business Wire |
| FDA Delays Ruling on Bristol-Myers Squibb Company, AstraZeneca PLC Diabetes Drug | October 27, 2011 | BioSpace |
| Bristol-Myers Squibb Delivers Strong Third Quarter with Important Clinical Data, Solid Operating Results and Continued Focus on Business Development | October 27, 2011 | Pharma News - Business Wire |
| Gilead, Bristol-Myers Squibb ink deal for HIV-fighting booster | October 26, 2011 | Health News - BizJournals.com |
| Bristol-Myers Squibb Company and Gilead Sciences, Inc. Announce Licensing Agreement for Development and Commercialization of New Fixed-Dose Combination Pill for People Living with HIV | October 26, 2011 | BioSpace - Breaking News |
| Bristol-Myers Squibb and Gilead Sciences Announce Licensing Agreement for Development and Commercialization of New Fixed-Dose Combination Pill for People Living with HIV | October 26, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb Senior VP Hooper departs | October 19, 2011 | Health News - CNBC |
| Bristol-Myers Squibb Announces Changes in Senior Management Team | October 19, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb Foundation Awards $2.12 Million in Grants to Help Returning Soldiers Heal Emotional Wounds of War | October 19, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company Skin-Cancer Drug Rejected by U.K. Cost Agency | October 14, 2011 | BioSpace |
| Bristol-Myers Squibb Foundation Announces Six New Grants to Bridge Gaps in Cancer Awareness, Prevention and Care in Central and Eastern Europe | October 14, 2011 | Inside Industry - Gen |
| FDA Adds New Warnings to Bristol-Myers Squibb Company Cancer Drug | October 12, 2011 | BioSpace |
| Bristol-Myers Squibb Company's Sprycel May Increase Hypertension Risk, FDA Says | October 11, 2011 | BioSpace |
| Bristol-Myers Squibb Company Foundation Announces Collaboration with World Health Organization's Stop TB Department to Strengthen Community Based Care of Tuberculosis Including HIV Co-Infection in Five African Countries | October 11, 2011 | BioSpace |
| Bristol-Myers Squibb Foundation Announces Collaboration with World Health Organization’s Stop TB Department to Strengthen Community Based Care of Tuberculosis Including HIV Co-Infection in Five African Countries | October 11, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb @ Year Highs | October 10, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb to Announce Financial Results for Third Quarter 2011 on October 27 | October 04, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb to Present New Data Demonstrating Company’s Leadership in Liver Disease at The Liver Meeting® / AASLD Annual Meeting | September 30, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb: Digging in | September 29, 2011 | Pharmaceutical - Moreover |
| Dr Jose Tabora of Bristol-Myers Squibb Gets AIChE Award for Excellence in Quality by Design [Professional Services Close - Up] | September 26, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company, GlaxoSmithKline CEOs Talk Strategy | September 23, 2011 | BioSpace |
| Bristol-Myers Squibb Company and Ambrx, Inc. Announce $24 Million Collaboration for Novel Biologics Programs in Diabetes and Heart Failure | September 22, 2011 | BioSpace - Breaking News |
| Bristol-Myers Squibb and Ambrx Announce Collaboration for Novel Biologics Programs in Diabetes and Heart Failure | September 22, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb and Ono Enter into Strategic Agreement for Anti-PD-1 Antibody, BMS-936558/ONO-4538, and ORENCIA (abatacept) | September 21, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb and Ono Enter into Strategic Agreement for Anti-PD-1 Antibody, BMS-936558/ONO-4538, and ORENCIA | September 21, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company Gains More Rights to Cancer Drug From Ono Pharmaceutical Company, Ltd. | September 21, 2011 | BioSpace |
| Bristol-Myers Squibb and Ono Enter into Strategic Agreement for Anti-PD-1 Antibody, BMS-936558/ONO-4538, and ORENCIA® (aba | September 21, 2011 | Pharmaceutical - Moreover |
| ONO PHARMACEUTICAL: Ono and Bristol-Myers Squibb Enter into Strategic Agreement for Anti-PD-1 Antibody,ONO-4538/BMS-936558,and ORENCIA®(abatacept),Rheumatoid Arthritis Agent(70.8KB) | September 21, 2011 | Pharmaceutical - Moreover |
| BRISTOL MYERS SQUIBB CO.: Bristol-Myers Squibb and Ono Enter into Strategic Agreement for Anti-PD-1 Antibody, BMS-936558/ONO-4538, and ORENCIA® (abatacept) | September 21, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb and Ono Enter into Strategic Agreement for Anti-PD-1 Antibody, BMS-936558/ONO-4538, and ORENCIA® (abatacept) | September 21, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb and Saladax Biomedical Expand Collaboration for Diagnostic Assays for Alzheimer’s Disease | September 20, 2011 | Pharma News - Business Wire |
| Scale-up Systems: Dr Jose Tabora of Bristol-Myers Squibb Wins AIChE Award for Excellence in Quality by Design (QbD) Award sponsored by DynoChem to be presented at Annual Meeting, 16-21 October, Minneapolis | September 19, 2011 | Pharmaceutical - Moreover |
| Scale-up Systems: Dr Jose Tabora of Bristol-Myers Squibb Wins AIChE Award for Excellence in Quality by Design (QbD) | September 19, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company's Once-Daily Hepatitis C Drug Works in Phase II Study | September 19, 2011 | BioSpace |
| Bristol-Myers Squibb Company Pegged as Takeover Target, Bets on MS Drug to Hang Onto Its Gains | September 19, 2011 | BioSpace |
| Bristol-Myers Squibb Company (BMY) and AstraZeneca PLC (AZN) Release: ONGLYZA(TM) (saxagliptin) When Added to Insulin in Adults with Type 2 Diabetes Maintained Reductions in Blood Sugar Levels (HbA1c) Over | September 16, 2011 | Biotechnology - Moreover |
| Bristol-Myers Squibb Company and AstraZeneca PLC Release: ONGLYZA(TM) (saxagliptin) When Added to Insulin in Adults with Type 2 Diabetes Maintained Reductions in Blood Sugar Levels (HbA1c) Over 52 Weeks in Investigational Study Extension
| September 16, 2011 | BioSpace - Breaking News |
| Trading Idea - Is Bristol-Myers Squibb close to Support? | September 12, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb completes acquisition of Amira Pharma | September 10, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Anuncia los Ganadores del Concurso REYATAZ® (sulfato de atazanavir) “Fight HIV Your Way” (Lucha contra el VIH a tu manera) 2011 | September 08, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company Trading Near $30.34 Resistance Level?
| September 08, 2011 | BioSpace - Breaking News |
| Bristol-Myers Squibb Completes Acquisition of Amira Pharmaceuticals | September 08, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb to Present at the Morgan Stanley Global Healthcare Conference | September 07, 2011 | Pharma News - Business Wire |
| BAC B.V. Collaborates in Providing Custom CaptureSelect(R) Affinity Ligands for Bristol-Myers Squibb Company's Adnectin(TM) Biotherapeutics
| August 16, 2011 | BioSpace - Breaking News |
| Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ESC Highlights | August 15, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb Announces the Winners of the 2011 REYATAZ® (atazanavir sulfate) “Fight HIV Your Way” Contest | August 15, 2011 | Pharma News - Business Wire |
| A Former Bristol-Myers Squibb Company Chemist & Her Murdered Spouse | August 05, 2011 | BioSpace |
| Acucela Inc. Appoints Former Bristol-Myers Squibb Company (BMY) and F. Hoffmann-La Roche Ltd. (RHHBY) Executive, Jaisim Shah, to the Companyâs Board of Directors | August 03, 2011 | Biotechnology - Moreover |
| Acucela Inc. Appoints Former Bristol-Myers Squibb Company and F. Hoffmann-La Roche Ltd. Executive, to the Company???s Board of Directors | August 03, 2011 | Biotechnology - Moreover |
| Acucela Appoints Former Bristol-Myers Squibb and F. Hoffman-La Roche AG Executive, Jaisim Shah, to the Company’s Board of Directors | August 03, 2011 | Biotech News - Business Wire |
| FDA Approves Bristol-Myers Squibb Canada's Self-injectable Form of RA Therapy Orencia | August 01, 2011 | BioSpace |
| Bristol-Myers Squibb Delivers Excellent Second Quarter with Global New Product Approvals, Important Clinical Data and Strong Financial Results | July 28, 2011 | Clinical Trials - Business Wire |
| Pfizer Inc. & Bristol-Myers Squibb Company Bloodthinner May Cause Bleeding With No Benefit | July 26, 2011 | BioSpace |
| Bristol-Myers Squibb Company to Pay Up to $475 Million for Amira Pharmaceuticals, Inc., Scoops Up Lung Drug | July 22, 2011 | BioSpace |
| Bristol-Myers Squibb to pay up to $475 million to acquire Amira, entering fibrotic disease area | July 22, 2011 | Pharmaceutical - Moreover |
| BRISTOL-MYERS SQUIBBDL-10: Bristol-Myers Squibb to Acquire Amira Pharmaceuticals | July 22, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb to Acquire Amira Pharmaceuticals Acquisition Marks Bristol-Myers Squibb's Entrance into Fibrotic Diseases, an Area of High Unmet Need that is Complementary to Current Therapeutic Areas of Focus | July 21, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb to Acquire Amira Pharmaceuticals | July 21, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb - Best Performing Pharmaceutical | July 21, 2011 | Pharmaceutical - Moreover |
| Data on Bristol-Myers Squibb Company (BMY)’s Investigational Treatment for Alzheimer’s Disease Demonstrate Potential Therapeutic Window at Doses Below 1 | July 21, 2011 | Biotechnology - Moreover |
| Data on Bristol-Myers Squibb Company???s Investigational Treatment for Alzheimer???s Disease Demonstrate Potential Therapeutic Window at Doses Below 100 mg in Phase II Safety and Tolerability Study | July 20, 2011 | BioSpace - Breaking News |
| FDA Panel Rejects AstraZeneca PLC, Bristol-Myers Squibb Company Diabetes Pill | July 20, 2011 | BioSpace |
| Research Report on Gilead Sciences, Inc. and Bristol-Myers Squibb Company - New Innovations Facilitate Recovery | July 20, 2011 | Marketwire - Pharma and Biotech |
| Panel Rejects AstraZeneca PLC, Bristol-Myers Squibb Company Diabetes Pill | July 20, 2011 | BioSpace |
| GlaxoSmithKline-Pfizer Inc. AIDS Pill May Dislodge Bristol-Myers Squibb Company's, Study Suggests
| July 19, 2011 | BioSpace |
| After Decades in the Industry, Ex MedImmune and Bristol-Myers Squibb Company Biotech Veteran Leads Gaithersburg's Zyngenia | July 15, 2011 | BioSpace |
| Bristol-Myers Squibb Company Returns Rights to Exelixis, Inc. Cancer Drug | July 15, 2011 | BioSpace |
| AstraZeneca PLC, Bristol-Myers Squibb Company Diabetes Pill Has Risks - FDA | July 15, 2011 | BioSpace |
| Bristol-Myers Squibb returns rights to Exelixis cancer drug | July 14, 2011 | Health News - BizJournals.com |
| Bristol-Myers Squibb Company Melanoma Drug Yervoy Gets EU Approval | July 14, 2011 | BioSpace - Breaking News |
| Merck Serono Reorganizes R&D, Attracts Former Bristol-Myers Squibb Company (BMY) Medical Head | July 07, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb to Announce Results for Second Quarter 2011 on July 28 | July 07, 2011 | Pharma News - Business Wire |
| Merck Serono Reorganizes R&D, Attracts Former Bristol-Myers Squibb Company Medical Head | July 07, 2011 | BioSpace |
| Bristol-Myers Squibb Company, Innate Pharma Announce $465 Million Deal for an Investigational Immuno-Oncology Biologic; to Receive $35 Million Upfront, Shares Soar | July 07, 2011 | BioSpace |
| Bristol-Myers Squibb Company, Innate Pharma Announce $465 Million Deal for an Investigational Immuno-Oncology Biologic, To Receive $35 Million Upfront | July 07, 2011 | BioSpace - Breaking News |
| Bristol-Myers Squibb and Innate Pharma Announce Breakthrough Global License Agreement for an Investigational Immuno-Oncology Biologic | July 06, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb Signs New Agreement to Expand Access to Reyataz® (atazanavir sulfate) in sub-Saharan Africa and India | June 28, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company, AstraZeneca PLC Diabetes Drug Triumphs in 2-Year Study; Also Shows Bladder, Breast Cancer Risk | June 27, 2011 | BioSpace |
| Bristol-Myers Squibb Foundation Awards $1.5 Million in Grants to Help African American Women Fight Type 2 Diabetes | June 24, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company, AstraZeneca PLC Diabetes Pill Faces Safety Hurdles
| June 23, 2011 | BioSpace |
| Bristol-Myers Squibb Company, Pfizer Inc. Blood Thinner Tops Warfarin in Stroke Study, Wows Investors | June 23, 2011 | BioSpace |
| Alder Biopharmaceuticals Inc. to Receive $15 Million Milestone Payment from Bristol-Myers Squibb Company for Initiation of Phase 2b Clinical Trial in Rheumatoid Arthritis of ALD518/BMS-945429 Antibody Therapeutic Against IL-6 | June 20, 2011 | BioSpace |
| Alder Biopharmaceuticals to Receive $15 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2b Clinical Trial in Rheumatoid Arthritis of ALD518/BMS-945429 Antibody Therapeutic Against IL-6 | June 20, 2011 | Biotech News - PR Newswire |
| Analysis: Data May Help Bristol-Myers Squibb Company/Pfizer Inc. Clot Drug Catch Rivals | June 17, 2011 | BioSpace |
| Bristol-Myers Squibb Company (BMY) to Take Part in 20 | June 16, 2011 | Biotechnology - Moreover |
| Bristol-Myers Squibb to Take Part in 2011 Wells Fargo Securities Healthcare Conference | June 16, 2011 | Biotech News - Business Wire |
| FDA Approves Bristol-Myers Squibb Company's Drug That Prevents Organ Rejection | June 16, 2011 | BioSpace |
| Bristol-Myers Squibb Gets Thumbs-Up on Transplant Drug | June 16, 2011 | Xconomy Life Sciences |
| Bristol-Myers Squibb Announces U.S. FDA Approval of NULOJIX® (belatacept) | June 15, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company, Sanofi (France) in Race for Drug Marketing Pact with BioCon Limited; Sources Say Oral Insulin Drug Could be Worth $1 Billion to Suitors | June 14, 2011 | BioSpace |
| Bristol-Myers Squibb Company Resolves Problems at Puerto Rico Plant | June 10, 2011 | BioSpace |
| Roche Melanoma Drug Cuts Risk Of Death By 63 Percent; Bests Bristol-Myers Squibb Company In Study | June 06, 2011 | BioSpace |
| Bristol-Myers Squibb Canada and Roche Enter into a Clinical Collaboration Agreement to Conduct Combination Studies with YERVOY(TM) (ipilimumab) and Vemurafenib | June 02, 2011 | BioSpace |
| Bristol-Myers Squibb Company and Roche Enter into a Clinical Collaboration Agreement to Conduct Combination Studies with YERVOY(TM) (ipilimumab) and Vemurafenib | June 02, 2011 | BioSpace |
| Bristol-Myers Squibb and Roche Enter into a Clinical Collaboration Agreement to Conduct Combination Studies with YERVOY™ (ipilimumab) and Vemurafenib | June 02, 2011 | FDA News - Business Wire |
| Bristol-Myers Squibb to Take Part in Goldman Sachs Health Care Conference June 8 | June 01, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb near Resistance | June 01, 2011 | Pharmaceutical - Moreover |
| Rx&D Welcomes its Newest Member: Bristol-Myers Squibb Canada | May 31, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb marks and controls up to 400 packages per minute with Zetes' Datamatrix solution | May 26, 2011 | Pharmaceutical - Moreover |
| AMRI to Receive Milestone Payment from Bristol-Myers Squibb for the Initiation of a Phase II Study | May 25, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb Receives CHMP Positive Opinion for YERVOY™ (ipilimumab) | May 23, 2011 | Pharma News - PharmiWeb |
| Pfizer Inc. and Bristol-Myers Squibb Company???s Eagerly Anticipated Blood Thinner Eliquis Gains European Approval | May 23, 2011 | BioSpace |
| Bristol-Myers Squibb - The 12 greenest companies in biopharma | May 20, 2011 | FiercePharma Manufacturing |
| New Data from Bristol-Myers Squibb Oncology Portfolio to be Presented at 2011 American Society of Clinical Oncology (ASCO) Annual Meeting | May 20, 2011 | Pharma News - Business Wire |
| New Market Report Now Available: Bristol-Myers Squibb Co.: PharmaVitae Profile | May 20, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company Expands Deal to Evaluate Tekmira Pharmaceuticals Corporation???s RNAi Delivery Technology | May 17, 2011 | BioSpace - Breaking News |
| AstraZeneca PLC's Brilique More Cost Effective Than Sanofi-Aventis (France) and Bristol-Myers Squibb Company's Clopidogrel for Acute Coronary Syndryome, New Data Suggests | May 10, 2011 | BioSpace |
| Bristol-Myers Squibb Company Initiates a Nationwide Voluntary Recall of Coumadin | May 03, 2011 | BioSpace |
| Bristol-Myers Squibb Company (BMY) Invites Public to Listen to Webcast of 20 | April 30, 2011 | Biotechnology - Moreover |
| Bristol-Myers Squibb Company Invites Public to Listen to Webcast of 2011 Annual Meeting | April 29, 2011 | BioSpace - Breaking News |
| Study Backs New Drug for Typhoid in Poor Countries, Bristol-Myers Squibb Company Study | April 29, 2011 | BioSpace |
| Bristol-Myers Squibb Invites Public to Listen to Webcast of 2011 Annual Meeting | April 29, 2011 | Pharma News - Business Wire |
| Study Backs New Bristol-Myers Squibb CompanyDrug for Typhoid in Poor Countries | April 29, 2011 | BioSpace |
| CORRECTING and REPLACING Bristol-Myers Squibb Delivers Excellent First Quarter with YERVOY™ (ipilimumab) Approval, Key R&D Milestones and Strong Financials | April 28, 2011 | Pharma News - PharmiWeb |
| Financial Report: Bristol-Myers Squibb 1Q11 | April 28, 2011 | Contract Pharma |
| Bristol-Myers Squibb Company Profit Beats Expectations | April 28, 2011 | BioSpace |
| Bristol-Myers Squibb Delivers Excellent First Quarter with YERVOY™ (ipilimumab) Approval, Key R&D Milestones and Strong Financials | April 28, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb to Present at Deutsche Bank Heath Care Conference | April 26, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company New Data on Investigational Agent Belatacept in Kidney Transplant Recipients to be Presented at 2011 American Transplant Congress | April 25, 2011 | BioSpace - Breaking News |
| Ensemble Therapeutics Corporation Achieves Milestone in Bristol-Myers Squibb Company Collaboration | April 12, 2011 | BioSpace - Breaking News |
| Ensemble Therapeutics Achieves Milestone in Bristol-Myers Squibb Collaboration Major Progress Developing Ensemblins Against Challenging Drug Targets Yields Payment to Ensemble and Transfer of Successful Program to BMS | April 12, 2011 | Pharmaceutical - Moreover |
| Ensemble Therapeutics Achieves Milestone in Bristol-Myers Squibb Collaboration | April 12, 2011 | Pharma News - Business Wire |
| Research and Markets: 2011 IMS Company Profile: Bristol-Myers Squibb Includes R&D Pipelines, Analysts Forecasts and Events | April 08, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company (BMY) to Announce Results for First Quarter 20 | April 07, 2011 | Biotechnology - Moreover |
| Bristol-Myers Squibb to Announce Results for First Quarter 2011 on April 28 | April 07, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company Interferon-Free Combo Cured Hepatitis Patients | April 04, 2011 | BioSpace - Breaking News |
| UK's Doesn't Back Use Of Bristol-Myers Squibb Company's Orencia | March 30, 2011 | BioSpace |
| Bristol-Myers Squibb Foundation picks Balls Food Stores for diabetes effort | March 28, 2011 | Health News - BizJournals.com |
| FDA Approves Bristol-Myers Squibb Company's YERVOY(TM) (ipilimumab) for the Treatment of Patients with Newly Diagnosed or Previously-Treated Unresectable or Metastatic Melanoma, the Deadliest Form of Skin Cancer | March 28, 2011 | BioSpace |
| FDA Approves New Bristol-Myers Squibb Company Treatment for a Type of Late-Stage Skin Cancer | March 25, 2011 | BioSpace |
| Bristol-Myers Squibb Company Melanoma Drug May Soon Hit US Market | March 24, 2011 | BioSpace |
| Bristol-Myers Squibb Company Reports Positive Results for Melanoma Drug | March 22, 2011 | BioSpace |
| Massive health insurance fraud alleged in Bristol-Myers Squibb case | March 18, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company (BMY) Bribed Doctors, California Commissioner Says | March 18, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company Bribed Doctors, California Commissioner Says | March 18, 2011 | BioSpace - Breaking News |
| Bristol-Myers Squibb and WuXi PharmaTech Announce Collaboration for a New Analytical and Stability Testing Facility Marketing and Licensing Agreements | March 16, 2011 | Biotechnology - Moreover |
| Bristol-Myers Squibb Company Awards Grant to the to Address U.S. HIV Medical Workforce Shortage | March 14, 2011 | BioSpace - Breaking News |
| Bristol-Myers Squibb Awards Grant to the American College of Physicians Foundation to Address U.S. HIV Medical Workforce Shortage | March 14, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb to Present at Barclays Capital Global Healthcare Conference | March 09, 2011 | Pharma News - Business Wire |
| KineMed Extends Partnership With Bristol-Myers Squibb For Alzheimer's Disease | March 09, 2011 | Biotechnology - Moreover |
| Bristol-Myers Squibb signs agreement with WuXi AppTec (WuXi PharmaTech) | March 08, 2011 | Pharmaceutical - Moreover |
| New Data on Multiple Bristol-Myers Squibb Company Investigational Hepatitis C Compounds to be Presented at The International Liver Congress 2011 | March 08, 2011 | BioSpace - Breaking News |
| Bristol-Myers Squibb and WuXi PharmaTech partner on new analytical and stability testing facility | March 08, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company (BMY) and WuXi PharmaTech Co., Ltd. Announce Collaboration for a New Analytical and Stability Testing Facility | March 08, 2011 | Biotechnology - Moreover |
| New Data on Multiple Bristol-Myers Squibb Investigational Hepatitis C Compounds to be Presented at The International Liver Congress 2011 | March 07, 2011 | Biotech News - Business Wire |
| Bristol-Myers Squibb Company and WuXi PharmaTech Co., Ltd. Announce Collaboration for a New Analytical and Stability Testing Facility | March 07, 2011 | BioSpace - Breaking News |
| Bristol-Myers Squibb and WuXi PharmaTech Announce Collabor... | March 07, 2011 | Biotechnology - Moreover |
| Bristol-Myers Squibb and WuXi PharmaTech Announce Collaboration for a New Analytical and Stability Testing Facility | March 07, 2011 | Pharma News - Business Wire |
| /C O R R E C T I O N -- Bristol-Myers Squibb and AstraZeneca/ | March 04, 2011 | Biotech News - PR Newswire |
| Bristol-Myers Squibb Names Elliott Sigal, M.D., Ph.D., to Board of Directors | March 01, 2011 | Pharma News - Business Wire |
| FDA Approves Bristol-Myers Squibb Company, AstraZeneca PLC Kidney Disease Label for Onglyza | February 24, 2011 | BioSpace |
| Bristol-Myers Squibb to Present at Citi 2011 Global Health Care Conference | February 23, 2011 | Pharma News - Business Wire |
| Former Employee Gets Year for Stealing Bristol-Myers Squibb Trade Secrets | February 17, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company, Otsuka Pharmaceutical Co., Ltd.'s ABILIFY(R) (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium or Valproate | February 17, 2011 | BioSpace |
| New Bristol-Myers Squibb Company, Pfizer Inc. Drug May Help Patients With Irregular Heartbeat Avoid Stroke | February 11, 2011 | BioSpace |
| Paladin Labs Inc. Acquires Tempra(R) from Bristol-Myers Squibb Company | February 02, 2011 | BioSpace |
| Eli Lilly and Company, Bristol-Myers Squibb Company Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab | February 02, 2011 | BioSpace |
| Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab | February 02, 2011 | Pharma News - PR Newswire |
| Bristol-Myers Squibb y el Alvin Ailey American Dance Theater anuncian la primera colaboración en su clase para expresar a través de la danza las historias de las personas afectadas por el VIH/SIDA | February 01, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company (BMY) Fourth Quarter Profit Dives | January 27, 2011 | Biotechnology - Moreover |
| Bristol-Myers Squibb Company Fourth Quarter Profit Dives 94% on Year-Earlier Asset Gain | January 27, 2011 | BioSpace |
| Bristol-Myers Squibb Company 4Q Sales Rise, Meet Expectations | January 27, 2011 | BioSpace |
| Bristol-Myers Squibb Delivers Solid Fourth Quarter Results in a Year Highlighted by Robust Clinical Data, Continued Execution of Strategic Transactions and Good Operating Performance | January 27, 2011 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company (BMY) to Keep a Seattle Presence; to Preserve About 2 | January 26, 2011 | Biotechnology - Moreover |
| Bristol-Myers Squibb Company, Sanofi-Aventis (France) Get 6-Month Extension Of Plavix Exclusivity | January 26, 2011 | BioSpace |
| Bristol-Myers Squibb Company to Keep a Seattle Presence; to Preserve About 275 ZymoGenetics, Inc. Jobs | January 26, 2011 | BioSpace |
| Bristol-Myers Squibb to Stay in Seattle, Keep ZymoGenetics Workers | January 26, 2011 | Xconomy Life Sciences |
| Bristol-Myers Squibb and sanofi-aventis Announce U.S. FDA Decision to Grant Pediatric Exclusivity For PLAVIX® | January 25, 2011 | FDA News - Business Wire |
| Bristol-Myers Squibb Company (BMY) to Announce Results for Fourth Quarter, Full Year 2010 on January | January 19, 2011 | Biotechnology - Moreover |
| Bristol-Myers Squibb Company to Announce Results for Fourth Quarter, Full Year 2010 on January 27 | January 18, 2011 | BioSpace - Breaking News |
| Bristol-Myers Squibb to Announce Results for Fourth Quarter, Full Year 2010 on January 27 | January 14, 2011 | Pharma News - Business Wire |
| Opko Health, Inc. to Partner with Bristol-Myers Squibb Company on Blood Test for Alzheimer's Disease | January 14, 2011 | BioSpace |
| Bristol-Myers Squibb Company Recalls Avalide Blood Pressure Drug | January 14, 2011 | BioSpace |
| Reportlinker Adds Bristol-Myers Squibb Co.: PharmaVitae Profile | January 11, 2011 | Pharma News - PR Newswire |
| Opko Health And Bristol-Myers Squibb Co. To Collaborate On Alzheimer's Test | January 10, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb and Pharmasset Enter into a Clinical Collaboration Agreement for Proof of Concept Combination Study in Patients Chronically Infected with Hepatitis C | January 10, 2011 | Biotech News - Business Wire |
| Pharmaceutical Science: Research from Bristol-Myers Squibb Company in the area of pharmaceutical science published | January 10, 2011 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb to Present at Goldman Sachs Healthcare CEOs Unscripted Conference | December 30, 2010 | Pharma News - Business Wire |
| Pfizer Inc. (PFE), Bristol-Myers Squibb Company (BMY) Blood Thinner Apixaban Beats Sanofi-Aventis (France) (SASY.PA) Drug Lovenox in Study | December 27, 2010 | Biotechnology - Moreover |
| Pfizer Inc., Bristol-Myers Squibb Company Blood Thinner Apixaban Beats Sanofi-Aventis (France) Drug Lovenox in Study | December 27, 2010 | BioSpace |
| Bristol-Myers Squibb Company and Oncolys BioPharma Enter Global Licensing Agreement for Investigational HIV Compound Worth $286 Million | December 20, 2010 | BioSpace |
| Bristol-Myers Squibb and Oncolys BioPharma Enter Global Licensing Agreement for Investigational HIV Compound | December 20, 2010 | Pharma News - Business Wire |
| Drug Research Gets New Asian Focus With Companies like Pfizer Inc., Johnson & Johnson and Bristol-Myers Squibb Company | December 15, 2010 | BioSpace |
| Bristol-Myers Squibb Hikes Dividend To 33 Cents | December 14, 2010 | Health News - Fox Business |
| Bristol-Myers Squibb Boosts Quarterly Dividend | December 14, 2010 | Health News - Fox Business |
| Bristol-Myers Squibb Company's Sprycel Wins European Market Approval for Chronic Myeloid Leukemia | December 10, 2010 | BioSpace |
| Bristol-Myers Squibb's Sprycel Wins European Market Approval | December 09, 2010 | Health News - Fox Business |
| Bristol-Myers Squibb Debt-Tender Offer Oversubscribed | December 03, 2010 | Health News - Fox Business |
| Bristol-Myers Squibb Announces the Expiration and Final Results of its Cash Tender Offer | December 03, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb and Alvin Ailey American Dance Theater Announce First-of-Its-Kind Collaboration to Express the Stories of People Impacted by HIV/AIDS Through Dance | December 01, 2010 | Pharma News - Business Wire |
| UK's NICE Backs Bristol-Myers Squibb's Schizophrenia Drug | December 01, 2010 | Health News - Fox Business |
| Bristol-Myers Squibb Company (BMY) and Sanofi-Aventis (France) (SASY.PA)'s Plavix, Aspirin Combo Tied To Hemorrhaging In Study | November 24, 2010 | Biotechnology - Moreover |
| Bristol-Myers Squibb Company and Sanofi-Aventis (France)'s Plavix, Aspirin Combo Tied To Hemorrhaging In Study | November 24, 2010 | BioSpace |
| Reportlinker Adds Bristol-Myers Squibb: Pipeline - Products - Performance - Potential | November 23, 2010 | Biotech News - PR Newswire |
| Research and Markets: Bristol-Myers Squibb: Pipeline, Products, Performance and Potential 2010 | November 23, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb faces overtime pay collective action by pharmaceutical reps | November 21, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company, Pfizer Inc. End Study on Anti-Clotting Drug Due to Bleeding | November 19, 2010 | BioSpace |
| Jeffrey Bethune files lawsuit against Bristol-Myers Squibb for denying overtime pay | November 19, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Announces the Pricing Terms of its Cash Tender Offer For Up to $750 Million Aggregate Principal Amount of its Outstanding Debt Securities | November 18, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb Sued for Denying Overtime Pay | November 18, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Sued for Denying Employees Overtime Pay | November 18, 2010 | Biotech News - PR Newswire |
| Bristol-Myers Squibb Announces the Early Results of its Cash Tender Offer For Up to $750 Million Aggregate Principal Amount of its Outstanding Debt Securities | November 17, 2010 | Pharma News - Business Wire |
| Patent Upheld On Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company Abilify Schizophrenia Medication | November 16, 2010 | BioSpace |
| How Bristol-Myers Squibb Partner Otsuka Pharmaceutical Won Ruling on Schizophrenia Treatment Patent- antipsychotic drug Abilify? | November 16, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Foundation Launches $100 Million Initiative Targeting America’s Type 2 Diabetes Crisis | November 11, 2010 | Pharma News - Business Wire |
| Use of Stomach Drugs With Bristol-Myers Squibb Company and Sanofi-Aventis (France)'s Plavix Is Backed | November 09, 2010 | BioSpace |
| Bristol-Myers Squibb Company Release: New Data Show That Subcutaneous Injection of an Investigational Formulation of ORENCIA(R) (abatacept) Provided Similar Improvements in Disease Activity Compared to Intravenous Administration of ORENCIA | November 08, 2010 | BioSpace - Breaking News |
| Data on Two Novel Investigational Bristol-Myers Squibb Compounds in Clinical Development for Patients with Rheumatoid Arthritis to Be Presented at the American College of Rheumatology Annual Scientific Meeting | November 06, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company's KOMBIGLYZE(TM) XR (Saxagliptin and Metformin HCl Extended-Release) Tablets Approved in the U.S. for the Treatment of Type 2 Diabetes Mellitus in Adults | November 05, 2010 | BioSpace |
| Bristol-Myers Squibb and Simcere Form Partnership | November 04, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb in deal to develop early-stage oncology compound with Chinas Simcere; to buy back $750 million of debt | November 04, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb to Present at the 2010 Annual Credit Suisse Health Care Conference | November 04, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb Announces Cash Tender Offer For Up to $750 Million Aggregate Principal Amount of its Outstanding Debt Securities | November 03, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company Announces that the U.S. FDA Has Extended the Review Timeline for the Ipilimumab Biologics License Application | November 03, 2010 | BioSpace - Breaking News |
| Simcere Pharmaceutical Group and Bristol-Myers Squibb Company Enter Innovative Partnership to Develop Early-Stage Oncology Compound | November 03, 2010 | BioSpace - Breaking News |
| FDA Decision On Bristol-Myers Squibb Company Cancer Drug, Ipilimumab Delayed | November 03, 2010 | BioSpace |
| Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Early-Stage Oncology Compound | November 03, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb Leukaemia Drug Approved in US | November 03, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Announces that the U.S. Food and Drug Administration Has Extended the Review Timeline for the Ipilimumab Biologics License Application | November 02, 2010 | FDA News - Business Wire |
| Bristol-Myers Squibb Company Cancer Drug, Sprycel Receives New Approval | October 28, 2010 | BioSpace |
| Financial Report: Bristol-Myers Squibb 3Q | October 26, 2010 | Contract Pharma |
| Bristol-Myers Squibb profit slips | October 26, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb sees 3Q profit dip 2 percent | October 26, 2010 | Health News - CNBC |
| Bristol-Myers Squibb Third Quarter Featured Solid Operating Performance, Robust Clinical Data and the Strategic Acquisition of ZymoGenetics | October 26, 2010 | Pharma News - Business Wire |
| Sanofi-Aventis (France) (SASY.PA) and Bristol-Myers Squibb Company (BMY) Wins $442 Million Award Against Bristol-Myers Squibb Company (BMY) Over Plavix Patent | October 20, 2010 | Biotechnology - Moreover |
| Sanofi-Aventis (France) and Bristol-Myers Squibb Company Wins $442 Million Award Against Bristol-Myers Squibb Company Over Plavix Patent | October 20, 2010 | BioSpace |
| FDA to Reiterate Warning on Bristol-Myers Squibb Company's Plavix-Prilosec Interaction | October 19, 2010 | BioSpace |
| FDA Approves Bristol-Myers Squibb Company's BARACLUDE(R) (entecavir) as a Treatment for Chronic Hepatitis B Patients | October 19, 2010 | BioSpace |
| Bend Research Announces Extension of Drug-Discovery Enablement and Development Services Agreement With Bristol-Myers Squibb Company | October 19, 2010 | BioSpace - Breaking News |
| Bristol-Myers Squibb Company (BMY) Release: My SPRYCEL(R) (dasatinib) Support Program Now Available for Patients | October 14, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company Completes Acquisition of ZymoGenetics, Inc. | October 13, 2010 | BioSpace - Breaking News |
| KINAXO Enters Agreement with Bristol-Myers Squibb Company | October 13, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Completes Acquisition of ZymoGenetics, Inc. | October 12, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb to Announce Results for Third Quarter 2010 on October 26 | October 12, 2010 | Pharma News - PharmiWeb |
| CORRECTING and REPLACING Bristol-Myers Squibb to Announce Results for Third Quarter 2010 on October 26 | October 12, 2010 | Pharma News - Business Wire |
| Exelixis, Inc. Licenses Two Drug Programs To Bristol-Myers Squibb Company; Nabs $60M Upfront, Potentially $505M More | October 11, 2010 | BioSpace |
| Exelixis Licenses Programs to Bristol-Myers Squibb Company | October 11, 2010 | FDA News - Business Wire |
| Bristol-Myers Squibb Completes Tender Offer for ZymoGenetics, Inc. with 94.9% of Shares Tendered | October 08, 2010 | Pharma News - Business Wire |
| Actelion Ltd. Jumps On Bristol-Myers Squibb Company Stake Talk; Companies Mum | October 07, 2010 | BioSpace |
| Bristol-Myers Squibb Company (BMY) Partners with Cegedim Dendrite Relationship Management For Next Generation Customer Relationship Management (CRM) Platform | October 06, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company Partners with Cegedim Relationship Management For Next Generation Customer Relationship Management (CRM) Platform | October 06, 2010 | Pharma News - Business Wire |
| Drug Firms Like Merck & Co., Inc., Bristol-Myers Squibb Company, and GlaxoSmithKline Face Bribery Probe | October 06, 2010 | BioSpace |
| C3i and Bristol-Myers Squibb to Discuss the Effects of Oracle Clinical 4.5.3 Zero Footprint on Support Services at the Oracle Health Sciences User Group Conference | October 05, 2010 | Biotech News - PR Newswire |
| New Data on Multiple Bristol-Myers Squibb Compounds to be Presented at AASLD 2010 | October 01, 2010 | Pharma News - Business Wire |
| ZymoGenetics and Bristol-Myers Squibb to Present PEG-Interferon Lambda Phase 2a Interim Clinical Trial Results at AASLD 2010 | October 01, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company Recalls Blood Pressure Drug Avalide | September 30, 2010 | BioSpace |
| Bristol-Myers Squibb Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of ZymoGenetics, Inc. | September 28, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company to Cut 3 Pct of Work Force | September 24, 2010 | BioSpace - Breaking News |
| AstraZeneca PLC, Bristol-Myers Squibb Company Diabetes Drug Dapagliflozin Succeeds in Latest Trial; Comparable to Pfizer Inc.'s Glipizide | September 24, 2010 | BioSpace - Breaking News |
| Bristol-Myers Squibb Company to Cut 3% of Work Force | September 24, 2010 | BioSpace - Breaking News |
| FDA Warns Bristol-Myers Squibb Company About GMP Violations at PR Plant | September 15, 2010 | BioSpace |
| FDA Warns Bristol-Myers Squibb Company About Violations at PR Plant | September 15, 2010 | BioSpace |
| Bristol-Myers Squibb to Present at the UBS Global Life Sciences Conference | September 13, 2010 | Pharma News - Business Wire |
| UK's National Institute for Clinical Excellence (NICE) Wants More Data on Bristol-Myers Squibb Company (BMY) And Otsuka America Pharmaceutical, Inc. Schizophrenia Drug Abilify | September 10, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company Begins Tender Offer to Acquire ZymoGenetics, Inc. | September 10, 2010 | BioSpace - Breaking News |
| UK's National Institute for Clinical Excellence (NICE) Wants More Data on Bristol-Myers Squibb Company And Otsuka America Pharmaceutical, Inc. Schizophrenia Drug Abilify | September 10, 2010 | BioSpace - Breaking News |
| UK's National Institute for Clinical Excellence (NICE) Wants More Data On Bristol-Myers Squibb Company And Otsuka Pharmaceutical Co., Ltd. Schizophrenia Drug Abilify | September 10, 2010 | BioSpace |
| Bristol-Myers Squibb Begins Tender Offer to Acquire ZymoGenetics, Inc. | September 10, 2010 | Pharma News - Business Wire |
| ZymoGenetics Shares Surge on Bristol-Myers Squibb Buyout | September 08, 2010 | Health News - Fox Business |
| Bristol-Myers Squibb to Present at the Morgan Stanley Global Healthcare Unplugged Conference | September 08, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company To Acquire ZymoGenetics, Inc. For $885 Million | September 08, 2010 | BioSpace |
| The Law Office of Robbins Umeda LLP Announces an Investigation of the Tender Offer by Bristol-Myers Squibb Company to Acquire ZymoGenetics, Inc. | September 08, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb To Buy ZymoGenetics | September 07, 2010 | Health News - Fox Business |
| Bristol-Myers Squibb To Buy Biotech ZymoGenetics For $836 Million | September 07, 2010 | Health News - Fox Business |
| Bristol-Myers Squibb to Acquire ZymoGenetics | September 07, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company, Pfizer Inc. Drug Cuts Stroke Risk By Half Vs Aspirin | August 31, 2010 | BioSpace - Breaking News |
| Immunoglobulins: Data on immunoglobulins described by researchers at Bristol-Myers Squibb Company | August 27, 2010 | Biotechnology - Moreover |
| Bristol-Myers Squibb Company and Pfizer Inc. Evaluate Unmet Need in Patients with Atrial Fibrillation | August 25, 2010 | BioSpace - Breaking News |
| Bristol-Myers Squibb and Pfizer Inc Evaluate Unmet Need in Patients with Atrial Fibrillation | August 25, 2010 | FDA News - Business Wire |
| Bristol-Myers Squibb Company Cancer Drug Gets Faster FDA Review | August 19, 2010 | BioSpace |
| Bristol-Myers Squibb Company's Ipilimumab Receives FDA Priority Review Designation for Adult Patients with Previously Treated Advanced Melanoma | August 18, 2010 | BioSpace - Breaking News |
| Research from Bristol-Myers Squibb Company provides new data about dosage forms | August 17, 2010 | Pharmaceutical - Moreover |
| Research and Markets: Bristol-Myers Squibb Co.: PharmaVitae Profile | August 17, 2010 | Biotech News - Business Wire |
| Dosage Forms: Research from Bristol-Myers Squibb Company provides new data about dosage forms | August 17, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company Release: Data on Investigational Drug Belatacept in Kidney Transplant Recipients to Be Presented at | August 16, 2010 | BioSpace - Breaking News |
| Bristol-Myers Squibb Company Release: Data on Investigational Drug Belatacept in Kidney Transplant Recipients to Be Presented at 23rd International Congress of The Transplantation Society | August 16, 2010 | BioSpace - Breaking News |
| Pharmaceutical Research: Research reports from Bristol-Myers Squibb Company provide new insights into pharmaceutical research | August 16, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb and ADAP Crisis Task Force Announce Enhanced, Multi-year Support for AIDS Drug Assistance Programs (ADAPs) in the United States | August 11, 2010 | Pharma News - Business Wire |
| On the Call: Bristol-Myers Squibb CEO Andreotti | July 22, 2010 | Health News - CNBC |
| Bristol-Myers Squibb National Survey Finds a Disparity Between Health Care Providers and HIV Positive Patients Perspectives on the Emotional Barriers to Seeking HIV Care and Treatment | July 22, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company Beats Forecast, on Lower Costs, Taxes | July 22, 2010 | BioSpace |
| Bristol-Myers Squibb Second Quarter Featured Robust Clinical Data and Double-Digit EPS Growth | July 22, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb Co.: PharmaVitae Profile | July 21, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb GmbH & Co. KGaA: Neu auf www.HepB.de - Interaktive Weltkarte hilft bei Reisevorbereitungen | July 21, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company Release: Recall of Coumadin 1 mg Tablet Blister Packs | July 14, 2010 | BioSpace - Breaking News |
| Bristol-Myers Squibb to Announce Results for Second Quarter 2010 on July 22 | July 13, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb starts recall of Coumadin | July 12, 2010 | Health News - CNBC |
| Bristol-Myers Squibb Company And Otsuka Pharmaceutical Co., Ltd. Release: SPRYCEL(R) (dasatinib) Receives FDA Priority Review for the Treatment of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase | July 12, 2010 | BioSpace - Breaking News |
| Bristol-Myers Squibb Company Release: SPRYCEL(R) (dasatinib) Receives FDA Priority Review for the Treatment of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase | July 12, 2010 | BioSpace - Breaking News |
| Bristol-Myers Squibb Company (BMY), Elan Corporation PLC (ELN), Genayme Corporation, Merck & Co., Inc. (MRK), Novartis Corporation (NVS), Pfizer Inc. (PFE) and Other Leaders in the Pharmaceutical Industry to Discuss Opportunities in Nanotechnology | July 08, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb picks Johnson Controls | July 08, 2010 | Pharmaceutical - Moreover |
| European Commission Approves Bristol-Myers Squibb Company's ORENCIA in Combination with Methotrexate for Earlier Use as First-Line Biologic after DMARD Inadequate Response for the Treatment of Rheumatoid Arthritis | July 07, 2010 | BioSpace |
| HIV/AIDS: Research from Bristol-Myers Squibb Company yields new findings on HIV/AIDS | July 02, 2010 | Biotechnology - Moreover |
| New Bristol-Myers Squibb Company, AstraZeneca PLC Diabetes Drug, Dapagliflozin Effective in Study | June 28, 2010 | BioSpace - Breaking News |
| New Bristol-Myers Squibb Company, AstraZeneca PLC Diabetes Drug Effective in Study | June 28, 2010 | BioSpace |
| Bristol-Myers Squibb Company Release: Dapagliflozin as Monotherapy Demonstrated Improved Glycemic Control in Treatment-Na??ve Adults with Type 2 Diabetes | June 22, 2010 | BioSpace - Breaking News |
| Exelixis, Inc. Regains Full Rights to Develop and Commercialize XL184; Bristol-Myers Squibb Company will Make $17 Million Payment in Connection with Return of Drug | June 21, 2010 | BioSpace |
| Saladax Biomedical Signs Deal with Bristol-Myers Squibb to Develop Clinical Diagnostics | June 21, 2010 | Pharma News - Business Wire |
| Reminder: Exelixis Announces June 21 Webcast of Conference Call Update on Development Collaboration with Bristol-Myers Squibb Company for XL184 | June 21, 2010 | FDA News - Business Wire |
| Exelixis Announces June 21 Webcast of Conference Call Update on Development Collaboration with Bristol-Myers Squibb Company for XL184 | June 19, 2010 | FDA News - Business Wire |
| Research and Markets: Bristol-Myers Squibb Co in Consumer Health Around the World | June 18, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company Release: New Data for Investigational Antibody Blocking IL-6 in Rheumatoid Arthritis Patients to be Presented at Annual Congress of European League Against Rheumatism | June 16, 2010 | BioSpace - Breaking News |
| Bristol-Myers Squibb Company Says Arthritis Drug Trial BMS-945429/ALD518 Met Goal | June 16, 2010 | BioSpace - Breaking News |
| Bristol-Myers Squibb to Present at the 2010 Wells Fargo Securities Health Care Conference | June 16, 2010 | Pharma News - Business Wire |
| Parexel and Icon partner with Bristol-Myers Squibb on "robust pipeline" | June 15, 2010 | Pharmaceutical - Moreover |
| Research and Markets: Bristol-Myers Squibb Company - Comprehensive SWOT Analysis: the Company Recorded Revenues of $18,808 Million During the Financial Year Ended December 2009 | June 15, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb Establishes Strategic Partnership With PAREXEL to Enable Greater Effectiveness in Clinical Development | June 14, 2010 | Biotech News - PR Newswire |
| Bristol-Myers Squibb Signs Agreements with ICON and PAREXEL to Support Greater Efficiencies in Clinical Development | June 14, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company And Pfizer Inc. Halt Stroke Trial As Drug Shows Benefit | June 11, 2010 | BioSpace |
| Bristol-Myers Squibb to Present at the Goldman Sachs Global Health Care Conference | June 08, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company And Otsuka Pharmaceutical Co., Ltd.'s SPRYCEL(R) (dasatinib) Surpasses Gleevec in Head to Head Trials | June 07, 2010 | BioSpace - Breaking News |
| Bristol-Myers Squibb Is Climbing On Study Results | June 07, 2010 | Pharmaceutical - Moreover |
| Skin Cancer Drug, Ipilimumab News Boosts Bristol-Myers Squibb Company Shares | June 07, 2010 | BioSpace |
| Melanoma Drug Unleashing Immune System in Bristol-Myers Squibb Company's Breakthrough | May 27, 2010 | BioSpace - Breaking News |
| Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO Highlights | May 27, 2010 | Pharma News - Business Wire |
| Exelixis, Inc. And Bristol-Myers Squibb Company Drug Slows Progress of a Deadly Brain Cancer | May 21, 2010 | BioSpace |
| Bristol-Myers Squibb to Present Data on 13 Oncology Compounds During 2010 American Society of Clinical Oncology (ASCO) Annual Meeting | May 20, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb to Present at Citi Global Health Care Conference | May 19, 2010 | Pharma News - Business Wire |
| Immunoglobulins: Scientists at Bristol-Myers Squibb Company publish research in immunoglobulins | May 16, 2010 | Biotechnology - Moreover |
| Bristol-Myers Squibb to Present at Bank of America Merrill Lynch Health Care Conference | May 10, 2010 | Pharma News - Business Wire |
| Tekmira Pharmaceuticals Corporation, Bristol-Myers Squibb Company Reach Gene Deal; to Pay $3 Million | May 10, 2010 | BioSpace |
| Bristol-Myers Squibb Company Board OKs $3 Billion Share Repurchase | May 05, 2010 | BioSpace |
| Bristol-Myers Squibb Announces Authorization of Up to $3 Billion Share Repurchase Program | May 04, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company Says FDA Issues Letter on Belatacept; Asks for More Information | May 03, 2010 | BioSpace |
| Bristol-Myers Squibb Company Inc.: Scientists at Bristol-Myers Squibb Company release new data on bristol-myers squibb company inc. | May 02, 2010 | Pharmaceutical - Moreover |
| Vascular Endothelial Growth Factor: New data from Bristol-Myers Squibb Company illuminate research in vascular endothelial growth factor | May 02, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Receives Complete Response Letter from FDA for Belatacept | May 01, 2010 | FDA News - Business Wire |
| Vascular Endothelial Growth Factor: Researchers at Bristol-Myers Squibb Company have published new data on vascular endothelial growth factor | May 01, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb to Present at Deutsche Bank Conference | April 30, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb Invites Public to Listen to Webcast of 2010 Annual Meeting | April 30, 2010 | Pharma News - Business Wire |
| Drugmakers Bristol-Myers Squibb Company, AstraZeneca PLC, And Sanofi-Aventis (France) Post Improved 1st-Quarter Profits And Sales, Rest Of Year Looks Less Rosy | April 30, 2010 | BioSpace |
| Sales results for Bristol-Myers Squibb drugs | April 29, 2010 | Health News - CNBC |
| Bristol-Myers Squibb 1Q Net Income Up 16% | April 29, 2010 | Health News - Fox Business |
| Financial Report: Bristol-Myers Squibb 1Q | April 29, 2010 | Contract Pharma |
| Bristol-Myers Squibb Company Trims Forecast Due to Health-Reform Costs | April 29, 2010 | BioSpace |
| Bristol-Myers Squibb Net Income Up 16% | April 29, 2010 | Health News - Fox Business |
| Bristol-Myers Squibb Reports Strong Sales, Earnings Performance in First Quarter | April 29, 2010 | Pharma News - Business Wire |
| Pfizer/Bristol-Myers Squibb's Apixaban Will Become Decision Resources' Proprietary Clinical Gold Standard in 2013 and Through 2018 for the Treatment of Venous Thromboembolism | April 28, 2010 | Pharma News - PR Newswire |
| Arthritis Therapy: New arthritis therapy findings from Bristol-Myers Squibb Company described | April 28, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company Parkinsons's Drug Acquired by Aton Pharma, Inc. | April 26, 2010 | BioSpace |
| Stavudine Therapy: Research from Bristol-Myers Squibb Company yields new findings on stavudine therapy | April 26, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company Compound Potent Against Hepatitis C | April 22, 2010 | BioSpace - Breaking News |
| Bristol-Myers Squibb to Announce Results For the First Quarter 2010 on April 29 | April 22, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb Receives LEED® Silver Certification for its Biologics Manufacturing Facility in Devens, Massachusetts | April 21, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company Inc.: Data from Bristol-Myers Squibb Company provide new insights into bristol-myers squibb company inc. | April 20, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company to Post Select Investigational Compound Data Updates on Company Website | April 16, 2010 | BioSpace - Breaking News |
| Bristol-Myers Squibb to Post Select Investigational Compound Data Updates on Company Website | April 16, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb - Worst Performing Pharmaceutical | April 14, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company Board Elects Chief Financial Officer | April 09, 2010 | BioSpace - Breaking News |
| Bristol-Myers Squibb names Bancroft CFO | April 08, 2010 | Health News - CNBC |
| Bristol-Myers Squibb Names Charles Bancroft CFO | April 08, 2010 | Health News - Fox Business |
| Bristol-Myers Squibb Board Elects Charles Bancroft Chief Financial Officer | April 08, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company Ex-CFO Wins Ruling in Criminal Case | April 08, 2010 | BioSpace |
| Atherosclerosis: Research from Bristol-Myers Squibb Company has provided new data on atherosclerosis | April 05, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company Inc.: Researchers from Bristol-Myers Squibb Company describe findings in bristol-myers squibb company inc. | April 03, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company Inc.: Research findings from Bristol-Myers Squibb Company update understanding of bristol-myers squibb company inc. | April 01, 2010 | Biotechnology - Moreover |
| Sanofi-Aventis (France), Bristol-Myers Squibb Company Antiplatelet Drug Gets EC Approval | March 24, 2010 | BioSpace |
| Pharmacokinetics: Data from Bristol-Myers Squibb Company provide new insights into pharmacokinetics | March 24, 2010 | Pharmaceutical - Moreover |
| Bedfordreport.com: Complimentary Analyst Research on Pharmaceuticals Such as Bristol-Myers Squibb Co. (NYSE: BMY), Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA), AstraZeneca plc (NYSE: AZN) and Pfizer, Inc. (NYSE: PFE) | March 23, 2010 | Pharmaceutical - Moreover |
| Bedfordreport.com: Complimentary Analyst Research on Pharmaceuticals Such as Bristol-Myers Squibb Co. (NYSE: BMY), Teva Pharmaceutical | March 23, 2010 | Pharmaceutical - Moreover |
| U.S. FDA Accepts New Drug Application For Once-Daily Fixed Dose Combination Of Bristol-Myers Squibb Company And AstraZeneca PLC's Onglyza(TM) (Saxagliptin) And Extended Release Metformin For The Treatment Of Type 2 Diabetes Mellitus In Adults | March 17, 2010 | BioSpace - Breaking News |
| Bristol-Myers Squibb Company , Sanofi-Aventis (France)'s Plavix Gets New U.S. FDA Warning | March 15, 2010 | BioSpace |
| Bristol-Myers Squibb Company, Sanofi-Aventis (France)'s Plavix Gets New U.S. FDA Warning | March 15, 2010 | BioSpace |
| Life Sciences: New life sciences in children study findings have been published by scientists at Bristol-Myers Squibb Company | March 14, 2010 | Pharmaceutical - Moreover |
| Sanofi-Aventis K.K. And Bristol-Myers Squibb Company Announce Important Updates to PLAVIX U.S. Prescribing Information; FDA Announces New Boxed Warning on Plavix | March 12, 2010 | BioSpace |
| Sanofi-aventis and Bristol-Myers Squibb Announce Important Updates to PLAVIX U.S. Prescribing Information | March 12, 2010 | FDA News - Business Wire |
| Bristol-Myers Squibb Company (BMY) CEO's 2009 Compensation Down | March 11, 2010 | Biotechnology - Moreover |
| Bristol-Myers Squibb Company CEO's 2009 Compensation Down 22% | March 10, 2010 | BioSpace |
| Bristol-Myers Squibb Company and AstraZeneca PLC Announce the Commencement of the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus Trial (SAVOR-TIMI 53) | March 09, 2010 | BioSpace - Breaking News |
| Bristol-Myers Squibb and AstraZeneca Announce the Commencement of the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus Trial (SAVOR-TIMI 53) | March 09, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb to Present at Cowen and Company Health Care Conference | March 08, 2010 | Pharma News - Business Wire |
| Isis Pharmaceuticals, Inc. Earns $6 Million Milestone Payment From Bristol-Myers Squibb Company for BMS-PCSK9Rx | March 08, 2010 | BioSpace - Breaking News |
| Isis Pharmaceuticals, Inc. Earns $6 Million Milestone Payment From Bristol-Myers Squibb Company for BMS-PCSK9Rx | March 08, 2010 | BioSpace - Breaking News |
| Isis Earns $6 Million Milestone Payment From Bristol-Myers Squibb for BMS-PCSK9Rx | March 08, 2010 | Pharma News - PR Newswire |
| Pfizer Inc. , Bristol-Myers Squibb Company's ADVANCE-2 Study Results Demonstrate Investigational Anticoagulant Apixaban Statistically Superior To Enoxaparin in Prevention of Venous Thromboembolism Following Knee Replacement Surgery | March 05, 2010 | BioSpace - Breaking News |
| Pfizer Inc. , Bristol-Myers Squibb Company Anti-Clot Drug Promising in New Trial | March 05, 2010 | BioSpace - Breaking News |
| Allergan and Bristol-Myers Squibb sign development agreement | March 04, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company Sets Baseline for Profits Post-Plavix | March 04, 2010 | BioSpace - Breaking News |
| Bristol-Myers Squibb to Highlight Strong Pipeline and Execution of BioPharma Strategy in Meeting with Investment Community | March 04, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company Inc.: Study findings from Bristol-Myers Squibb Company broaden understanding of bristol-myers squibb company inc. | March 04, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb could pay Allergan US$413M in licensing deal for neuropathic pain drug | March 03, 2010 | Health News - CNBC |
| Bristol-Myers Squibb Company Names as CEO | March 03, 2010 | BioSpace - Breaking News |
| Bristol-Myers Squibb Company , Allergan Inc. in Pact for New Pain Drug; to Pay $40 Million; up to $373 Million in Milestones | March 03, 2010 | BioSpace - Breaking News |
| Bristol-Myers Squibb and Allergan Enter Global Agreement on Investigational Neuropathic Pain Medicine | March 03, 2010 | Pharma News - Business Wire |
| ExonHit annonce la signature d’un accord de licence entre Allergan et Bristol-Myers Squibb pour EHT/AGN 0001 | March 03, 2010 | Pharma News - Business Wire |
| Alopecia: Studies from Bristol-Myers Squibb Company update current data on alopecia | March 03, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb (BMY) Names Lamberto Andreotti CEO, As James Cornelius Steps Aside | March 02, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Names Lamberto Andreotti CEO, Effective May 4; James Cornelius to Retire as CEO, Remain as Chairman | March 02, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb Announces Dividend | March 02, 2010 | Pharma News - Business Wire |
| U.S. FDA Panel Backs Bristol-Myers Squibb Company Transplant Drug | March 02, 2010 | BioSpace - Breaking News |
| U.S. FDA Panel Backs Bristol-Myers Squibb Company Transplant Drug | March 02, 2010 | BioSpace |
| Bristol-Myers Squibb Company Inc.: Researchers' work from Bristol-Myers Squibb Company focuses on bristol-myers squibb company inc. | February 26, 2010 | Biotechnology - Moreover |
| Bristol-Myers Squibb Company Faces Challenges Getting FDA Approval for New Drug | February 26, 2010 | BioSpace |
| Bristol-Myers Squibb to Provide Business Update to Investment Community on March 4 | February 22, 2010 | Pharma News - Business Wire |
| Patton Boggs Lands Top Bristol-Myers Squibb Exec | February 19, 2010 | Pharmaceutical - Moreover |
| Former Bristol-Myers Squibb Lobbyist Joins Patton Boggs | February 18, 2010 | Pharmaceutical - Moreover |
| Top Bristol-Myers Squibb Executive Joins Patton Boggs | February 18, 2010 | Pharma News - PR Newswire |
| Autoimmune Diseases Clinical Trial: Reports summarize autoimmune diseases clinical trial research from Bristol-Myers Squibb Company | February 06, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb to freeze salaries in 2010 | February 05, 2010 | Health News - CNBC |
| Research and Markets: Partnering Agreements with Bristol-Myers Squibb - 2010 | February 05, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company (BMY) Freezes Salaries for | February 04, 2010 | Biotechnology - Moreover |
| Bristol-Myers Squibb Company Freezes Salaries for 2010 | February 04, 2010 | BioSpace |
| Bristol-Myers Squibb Company Inc.: Studies from Bristol-Myers Squibb Company in the area of bristol-myers squibb company inc. described | February 01, 2010 | Pharmaceutical - Moreover |
| Hepatitis C Virus Therapy: Findings from Bristol-Myers Squibb Company, Department of Virology broaden understanding of hepatitis C virus therapy | February 01, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb Company Beats Forecast, Helped by Lower Taxes | January 28, 2010 | BioSpace - Breaking News |
| Financial Report: Bristol-Myers Squibb 4Q09 | January 28, 2010 | Contract Pharma |
| Bristol-Myers Squibb Company , After Nutrition Business Sale, Has New Pure Pharma Focus, $8B for Deals | January 27, 2010 | BioSpace - Breaking News |
| Bristol-Myers Squibb Company, After Nutrition Business Sale, Has New Pure Pharma Focus, $8B for Deals | January 27, 2010 | BioSpace |
| European Commission Approves Bristol-Myers Squibb Company's ORENCIA(R) (abatacept) in Combination with Methotrexate for Children with Moderate to Severe Polyarticular Juvenile Idiopathic Arthritis (pJIA)
| January 25, 2010 | BioSpace - Breaking News |
| Clinical Trial Research: Reports outline clinical trial research study findings from Bristol-Myers Squibb Company | January 25, 2010 | Pharmaceutical - Moreover |
| Bristol-Myers Squibb to Present at J.P. Morgan Healthcare Conference | January 06, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb to Announce Results For the Fourth Quarter and Full Year of 2009 on January 28 | January 05, 2010 | Pharma News - Business Wire |
| Bristol-Myers Squibb Company and Mead Johnson Nutrition Company Announce Final Results of the Exchange Offer | December 23, 2009 | BioSpace - Breaking News |
| Bristol-Myers Squibb Company and Mead Johnson Nutrition Company Announce Preliminary Results of the Exchange Offer | December 18, 2009 | BioSpace - Breaking News |
| Bristol-Myers Squibb Company Says CFO to Resign | December 14, 2009 | BioSpace |
| US FDA Panel Has Child Weight Concerns About Bristol-Myers Squibb Company's Drug, Abilify | December 09, 2009 | BioSpace |
| Bristol-Myers Squibb Company $125 Million Plavix Accord Is Approved | December 09, 2009 | BioSpace |
| Bristol-Myers Squibb Company $125 Million Plavix Accord Is Approved | December 09, 2009 | BioSpace - Breaking News |
| US FDA Panel Has Child Weight Concerns About Bristol-Myers Squibb Company's Drug, Abilify | December 09, 2009 | BioSpace |
| Tranzyme Pharma Enters Into $16 Million Strategic Drug Discovery Collaboration with Bristol-Myers Squibb Company ; Total Milestone Payments Could Reach Up to Approximately $80 Million | December 08, 2009 | BioSpace |
| Tranzyme Pharma Enters Into $16 Million Strategic Drug Discovery Collaboration with Bristol-Myers Squibb Company; Total Milestone Payments Could Reach up to Approximately $80 Million | December 08, 2009 | BioSpace |
| Tranzyme Pharma Enters Into Strategic Drug Discovery Collaboration with Bristol-Myers Squibb Company; Total Milestone Payments Could Reach up to Approximately $80 Million | December 08, 2009 | BioSpace |
| Bristol-Myers Squibb Company, Pfizer Inc. to Seek Apixaban Approval | December 07, 2009 | BioSpace - Breaking News |
| Asterand plc Announces Extension of Agreement with Bristol-Myers Squibb Company | November 23, 2009 | BioSpace |
| FDA Approves Bristol-Myers Squibb Company , Otsuka Pharmaceutical Co., Ltd.'s ABILIFY(R) (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years) | November 23, 2009 | BioSpace |
| Bristol-Myers Squibb and Mead Johnson Announce Final Results of the Exchange Offer | | Pharma News - Business Wire |
| Bristol-Myers Squibb Updates 2009 Continuing Operations Financial Guidance | | Pharma News - Business Wire |
| Bristol-Myers Squibb Announces Dividend Increase | | Pharma News - Business Wire |
| Bristol-Myers Squibb and Mead Johnson Announce Preliminary Results of the Exchange Offer | | Pharma News - Business Wire |
| Bristol-Myers Squibb Sets Exchange Ratio of 0.6313 for the Exchange Offer | | Pharma News - Business Wire |
| Bristol-Myers Squibb Announces Appointment of Charles Bancroft as Acting Chief Financial Officer | | Pharma News - Business Wire |
| Facet Biotech and Bristol-Myers Squibb Report Promising Phase I/II Interim Data for Elotuzumab in Patients with Relapsed Multiple Myeloma | | Pharma News - Business Wire |
| ADDING MULTIMEDIA Bristol-Myers Squibb And Pfizer Announce Plans To Submit Regulatory Filing For Apixaban In Europe | | Pharma News - Business Wire |
| Bristol-Myers Squibb And Pfizer Announce Plans To Submit Regulatory Filing For Apixaban In Europe | | Pharma News - Business Wire |
| Bristol-Myers Squibb and Mead Johnson Announce Amendment and Extension of Exchange Offer | | Pharma News - Business Wire |
| New Data on Bristol-Myers Squibb Oncology Compounds to be Featured in Oral Presentations at 51st Annual Meeting of the American Society of Hematology | | FDA News - Business Wire |
